Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 13NETWORK 4NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 4Leukemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Hodgkin Disease 3Multiple Myeloma 2Anemia, Refractory, with Excess of Blasts 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Graft vs Host Disease 1Congenital Abnormalities 1Anemia, Refractory 1Anemia, Aplastic 1

Interventions

fludarabine phosphate 4fludarabine 3Mycophenolic Acid 3Filgrastim 3Cytarabine 3Cyclophosphamide 3revumenib 2Whole-Body Irradiation 2Mesna 2Bone Marrow Transplantation 2pegaspargase 1Vincristine 1Thiotepa 1Stem Cell Transplantation 1Standard of Care 1Sirolimus 1Midazolam 1Melphalan 1MRX-2843 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fentanyl 1Dexamethasone 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Cobicistat 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Leukemia, Biphenotypic, Acute × Busulfan × Clear all
NCT05170828 2026-02-24

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Ossium Health, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡